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Background: Interposition of a reversed jejunal loop in short bowel sydrome has previously been investigated in
human along with animal models and seemed able to facilitate intestinal adaptation. However, it is unclear if
growth hormone and insulin, well known for their implication in short bowel pathophysiology, intervene on this
effect.
Findings: Porcine models were randomly allocated to two cohorts: (1) short bowel (SB) group (n = 8) and (2) short
bowel reverse jejunal segment (SB-RS) group (n = 8). Amongst other parameters serum growth hormone and
insulin were measured at baseline, as well as on postoperative day 30 and 60.
Conclusion: Both endogenous hormones failed to demonstrate significant difference in respect to potential direct
effect to mechanisms of enhanced intestinal adaptation in reversed group
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Regulation of intestinal epithelial loss response is attrib-
uted to a complex multistage process with involvement
of many different factors [1] including hormones, en-
dogenous intestinal secretions, growth factors and cyto-
kines in immediate interaction with nutrient load and
composition [1-3].
A recent meta-analysis has highlighted the promising
features of exogenously administered human growth
hormone to adult patients with short bowel syndrome
[4]. In parallel, the enhancing effect mediated by exogen-
ous oral insulin on intestinal regrowth has been sup-
ported by animal models [5].
Our most recent article on the subject [6] consists of
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distribution, and reproduction in any mediumsuggested to be able to enhance intestinal adaptation at
a histopathological level and to favorably modify transit
time. Importantly, however, these putatively beneficial
actions were not reflected upon body weight [6]. This
data builds upon the previous evidence and is a follow-on
to this previous research work, assessing endogenous
growth hormone and insulin in our experimental setting.Material and methods
As described previously6, the pigs were randomly allo-
cated to two groups: (1) short bowel (SB) group (n = 8)
and (2) short bowel reverse jejunal segment (SB-RS)
group (n = 8). Intestinal transit time and nutritional sta-
tus (weight and serum albumin) evaluation along with
histopathological study and immunohistochemical ana-
lysis of small bowel tissue specimens were performed. In
addition serum Growth Hormone (Brio 2,Elisa 96,USA)
and Insulin (Immulite 1000, DPC,USA) were measured
at baseline, as well as on postoperative day 30 and 60.
The differences between the two groups were evaluatedntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 GH and Insulin values in (μΙU/ml)
Group SB Group SB-RS p
GH baseline 0.27 ± 0.16 0.30 ± 0.16 0.562
GH2 (Post-op D 30) 0.35 ± 0.07 0.32 ± 0.16 0.672
GH final (Post-op D 60) 0.40 ± 0.14 0.42 ± 0.14 0.712
Ins baseline 4.10 ± 2.44 4.11 ± 3.65 0.495
Ins2 (Post-op D 30) 3.94 ± 1.94 3.71 ± 1.87 0.833
Ins final (Post-op D 60) 3.64 ± 2.03 2.51 ± 1.07 0.207
*P values derived from Mann–Whitney-Wilcoxon test for independent samples.
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samples. Statistical analysis was performed with STATA
8.0 statistical software (Stata Corporation, College Station,
TX, USA).
Findings
No significant differences were demonstrated regarding
growth hormone (μΙU/ml) (SB group vs. SB-RS group,
mean ± SD: 0.27 ± 0.16 vs. 0.30 ± 0.16, p = 0.562 at base-
line; 0.35 ± 0.07 vs. 0.32 ± 0.16, p = 0.672 on postoperative
day 30; 0.40 ± 0.14 vs. 0.42 ± 0.14, p = 0.712 on post-
operative day 60). Similarly, no significant differences
were demonstrated regarding insulin (μΙU/ml) (SB group
vs. SB-RS group, mean ± SD: 4.10 ± 2.44 vs. 4.11 ± 3.65,
p = 0.495 at baseline; 3.94 ± 1.94 vs. 3.71 ± 1.87, p = 0.833
on postoperative day 30; 3.64± 2.03 vs. 2.51± 1.07,
p = 0.207 on postoperative day 60) (Table 1), (Figures 1,2)
Discussion
The results suggest a similar outcomes to previous data.
The documented difference between two groups, inFigure 1 Diagram demonstrates growth hormone values (μΙU/ml) (me
SB-RS group (red).intestinal growth and proliferation, was attributed at a cer-
tain extent on the triggering of the increased decelerated
nutrient load [1-3,6]. In several previous studies endogen-
ous insulin and growth hormone have been reported as
potent stimulants in intestinal turnover and potentially
beneficial factors in the treatment of short bowel syn-
drome as part of their main anabolic and general regula-
tory action to overall body metabolic rate and weight
balance [7,8]. Actions of GH mediated by Insulin Growth
Factor 1 stimulation, resulting in trophic effects in intes-
tinal mucosa in addition with enhancement of intracellular
transportation of nutrient constituents [1,7,8]. Similarly in-
sulin is known to be involved in modulation of growth and
differentiation of small bowel [5].
The lacks of substantial differences in both factors’
levels appear mainly to reflect the lack of significant
weight gain after the interposition in our experimental
setting. It may thus be postulated that the histopatho-
logically demonstrated enhanced intestinal adaptation
after the interposition [6] and the nutritional status rep-
resent two distinct variables which do not obligatorily
correlate with each other. In parallel with the above it is
well known that main source of production of both hor-
mones is other than small bowel and secretion is subject
to different stimuli and multifarious regulation systems.
Indeed, in agreement with the present findings, serum
albumin had not exhibited significant changes [6].
Given these findings on endogenous hormones, the fu-
ture experimental studies should focus on the effect of
exogenously administered growth hormone or insulin
upon intestinal adaptation after the interposition of a
reversed jejunal segment.an± SD) in 2 groups during observation time. SB group (green) vs.
Figure 2 Diagram demonstrates insulin values (μΙU/ml) (mean± SD) in 2 groups during observation time. SB group (green) vs. SB-RS
group (red).
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